Given the well-established glucocorticoid resistance in depressed patients54, the authors speculated that patients with treatment-resistant depression (and potentially patients with psychotic depression) are not able to compensate for GR resistance by increasing MR function. This evidence concerns the gene NR3C2 and depressive symptom measurement.